Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001144204-15-035417
Filing Date
2015-06-04
Accepted
2015-06-04 11:35:32
Documents
7
Period of Report
2015-05-15
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A v412372_8ka.htm 8-K/A 21697
2 EXHIBIT 23.1 v412372_ex23-1.htm EX-23.1 2923
3 EXHIBIT 99.1 v412372_ex99-1.htm EX-99.1 131471
4 EXHIBIT 99.2 v412372_ex99-2.htm EX-99.2 53788
5 EXHIBIT 99.3 v412372_ex99-3.htm EX-99.3 104002
6 GRAPHIC tex99-1_logo.jpg GRAPHIC 7660
7 GRAPHIC tex99-1_sig.jpg GRAPHIC 2571
  Complete submission text file 0001144204-15-035417.txt   329643
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
PLASMATECH BIOPHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-15771 | Film No.: 15912283
SIC: 2834 Pharmaceutical Preparations